Mauro Turrini earns acclaim as a regulatory expert who advises clients on a range of matters including clinical trial agreements and market access strategies.
Mauro has built a strong reputation as an expert in the intellectual property and life sciences fields.
Mauro is counsel and member of the international intellectual property and life sciences groups, based in Milan and Rome.
He has over 15 years' experience advising clients on intellectual property (patent, know-how, trademark, design and copyright) and life sciences matters (ie, medicinal products, medical devices, food supplements, food and plant protection products), covering a vast range of issues including authorisation and certification issues and market access as well as compliance issues.
Before joining the firm in 2008, Mauro spent a number of years working for the Italian Medicines Agency (AIFA) and the European Medicines Agency (EMA). During his time at the EMA, Mauro was responsible for all legal matters relating to intellectual property protection and innovation development. He provided legal support to the Paediatric Committee (PDCO) and the Name Review Group (NRG) and also contributed to the advanced therapy regulation implementation. While there, Mauro was responsible for providing a full range of pharmaceuticals advice, including generics and data exclusivity issues, biosimilars, parallel import and parallel distribution issues, orphan drugs, SMEs and transparency issues. Mauro was also a member of the EMA innovation task force (ITF), a team within the European Agency specialised in product classification and borderline issues.
After studying law at Bologna University, he completed his legal training and qualified in 2005. He has also completed, with merit, an intensive course in IP law in 2006. He regularly speaks and writes on intellectual property law and life sciences matters.Mauro’s native language is Italian. He is also fluent in English, French and Spanish, and has a working knowledge of Portuguese.